SOP Guide for Pharma

Sterile Injectable Manufacturing: SOP for Review of Batch Manufacturing Records – V 2.0

Sterile Injectable Manufacturing: SOP for Review of Batch Manufacturing Records – V 2.0

Standard Operating Procedure for Review of Batch Manufacturing Records


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/081/2025
Supersedes SOP/SIM/081/2022
Page No. Page 1 of 13
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

This SOP defines the systematic approach to reviewing Batch Manufacturing Records (BMR) in sterile injectable manufacturing to ensure completeness, accuracy, and compliance with GMP regulations.

2. Scope

This procedure applies to Quality Assurance personnel responsible for reviewing BMRs for sterile injectable products prior

to batch release.

3. Responsibilities

  • Production Officer: Responsible for timely and accurate completion of BMR entries.
  • QA Officer: Responsible for thorough review of BMR against executed activities and documentation.
  • Head QA: Final reviewer and approver for BMR and batch release recommendation.

4. Accountability

The Head of Quality Assurance is accountable for ensuring all BMRs are thoroughly reviewed and meet compliance standards prior to batch disposition.

5. Procedure

5.1 Receipt and Initial Check

  1. Production hands over the completed BMR with all attachments (IPC results, raw material tags, cleaning records, etc.) to QA.
  2. QA checks for completeness using a BMR checklist (Annexure-1).

5.2 Detailed Page-by-Page Review

  1. Verify material issuance, batch number traceability, and reconciliation entries.
  2. Cross-check IPC values with IPC reports and QA sign-offs.
  3. Ensure cleaning records, equipment usage logs, and calibration status are attached and filled.
  4. Ensure signatures, timestamps, and data entries follow ALCOA+ principles.

5.3 Critical Observations

  1. Identify missing entries, overwriting, unapproved corrections, or gaps.
  2. Record observations in the BMR Review Observation Sheet (Annexure-2).
  3. Communicate observations to production for clarification or CAPA (Corrective and Preventive Action).

5.4 Documentation Corrections

  1. Allow corrections only with justification, sign, and date.
  2. Ensure no use of whitener or unauthorized modification in GMP documents.

5.5 Final QA Review Summary

  1. Summarize BMR review outcome in the BMR Review Summary Log (Annexure-3).
  2. Only approved BMRs shall proceed to batch release review.

6. Abbreviations

  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
  • IPC: In-Process Control
  • GMP: Good Manufacturing Practices
  • CAPA: Corrective and Preventive Action
  • ALCOA+: Attributable, Legible, Contemporaneous, Original, Accurate + Complete, Consistent, Enduring, Available

7. Documents

  1. BMR Review Checklist – Annexure-1
  2. BMR Review Observation Sheet – Annexure-2
  3. BMR Review Summary Log – Annexure-3

8. References

  • WHO TRS 986 Annex 2: GMP for Sterile Pharmaceutical Products
  • 21 CFR Part 211 – Good Manufacturing Practice for Finished Pharmaceuticals
  • ICH Q10 – Pharmaceutical Quality System

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: BMR Review Checklist

Item Status Remarks
All pages present and numbered Yes Verified
IPC entries signed Yes Complete

Annexure-2: BMR Review Observation Sheet

Observation No. Description Action Taken Reviewer Date
OBS-041 Missing pH value in IPC Updated by operator Sunita Reddy 18/06/2025

Annexure-3: BMR Review Summary Log

Batch No. Reviewed By Review Date Outcome Remarks
INJ-8804 Rajesh Kumar 18/06/2025 Accepted No major discrepancies

Revision History

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial release New SOP QA Head
18/06/2025 2.0 Updated checklist and ALCOA+ alignment Compliance enhancement QA Head
Exit mobile version